Shot B

Quick links to important sections

Shot B

Method of action: Vitamins

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Shot B

Quick Facts

Classification Common Active Ingredient Administration Route
Vitamin Supplement or Vaccine Vitamin B12 (Cyanocobalamin) or Hepatitis B Antigen Intramuscular (IM) or Subcutaneous (SC) Injection

The term “Shot B” commonly refers to one of two distinct medical injections: a Vitamin B complex injection or the Hepatitis B vaccine. The specific product and purpose must be determined by a healthcare provider.

Vitamin B Injections

A Vitamin B complex injection is a sterile solution containing a blend of essential B vitamins, often including vitamin B12 (cyanocobalamin) or a combination of B1, B2, B3, B5, B6, and B12. These injections are primarily used to prevent or treat conditions associated with a vitamin deficiency, such as pernicious anemia, or in patients with gastrointestinal disorders that prevent proper nutrient absorption from oral supplements.

Because the vitamins are delivered directly into the muscle (intramuscularly) or under the skin (subcutaneously), this method bypasses the digestive system for rapid and effective absorption.

Hepatitis B Vaccine

Alternatively, “Shot B” may refer to the Hepatitis B (HepB) vaccine. This vaccine contains an inactive protein from the hepatitis B virus and is administered to prevent infection with the virus, which can cause serious liver diseases like cirrhosis and liver cancer. It works by stimulating the body to produce protective antibodies against the virus, offering long-term immunity. Vaccination is widely recommended for all infants at birth, as well as for all adults who are not previously vaccinated.

Regulatory References

  1. NIH MedlinePlus Drug Information (Cyanocobalamin Injection)

What side effects are possible with Shot B?

Possible Side Effects and Safety Information

The term Shot B commonly refers to either a Vitamin B12 Injection (Cyanocobalamin) or the Hepatitis B Vaccine. The officially documented safety profile and potential adverse reactions are distinct for each, as categorized in government regulatory labeling.


Vitamin B12 Injection (Cyanocobalamin)

Adverse reactions listed in regulatory documents involve the gastrointestinal, nervous, and integumentary systems. Commonly documented effects include headache, nausea, mild transient diarrhea, and localized pain or soreness at the injection site. Serious adverse reactions, though rare, are officially documented and include Anaphylactic Shock, Pulmonary Edema, and Congestive Heart Failure, particularly early in treatment. The injection is contraindicated in individuals with a known hypersensitivity to any of its components or to cobalt.


Hepatitis B Vaccine

Side effects are classified by frequency according to regulatory standards (e.g., EMA/ICH). Very Common reactions (ge 1/10) include pain, swelling, or redness at the injection site, fever, and fatigue. Common reactions (ge 1/100 to <1/10) include headache, diarrhea, and nausea. Serious but rare adverse reactions documented in official labeling include Anaphylaxis and rare neurological disorders such as Guillain-Barré Syndrome. The vaccine is contraindicated in persons with known hypersensitivity to the vaccine's components, including yeast, or following a severe reaction to a previous dose.


This structured safety information, derived from official prescribing documents, establishes the risk framework and critical limitations for each product.

Overdose and Emergency Response

The term Shot B refers to two distinct products: a Vitamin B12 Injection (e.g., Cyanocobalamin) or the Hepatitis B Vaccine. Overdose guidance is strictly governed by specific regulatory statements for each product.

Official Overdose Statements

Product Documented Overdose Presentation
Vitamin B12 Injection Regulatory labeling states that no overdosage has been reported with this product.
Hepatitis B Vaccine The official regulatory profile states that the adverse event profile reported with over-administration is comparable to that observed with the recommended dose.

Required Emergency Action

For the Vitamin B12 Injection, official labeling mandates that immediate medical attention must be sought for any signs of severe hypersensitivity reactions, such as anaphylactic shock, which are reported severe outcomes of administration. Other serious outcomes noted include pulmonary edema.

For the Hepatitis B Vaccine, immediate medical attention is required for serious reactions, including severe outcomes noted in the adverse event profile, such as seizures or neurological disorders.

Overdose Structure

In both instances, no specific antidote is documented in the official prescribing information. The overall overdose profile is defined by the requirement for an emergency response to life-threatening severe effects, which mandates the action to seek immediate medical attention as described in the official labeling.

Therapeutic Uses of Shot B

Quick Facts

  • Primary Benefit: Helps to prevent illness caused by Hepatitis B virus infection.
  • Key Indication: Supports immunity against the virus.
  • Patient Group: Administered across various age groups, including infants, adolescents, and adults.

Shot B, a common name for the Hepatitis B vaccine, is an agent administered to help the body develop defense against infection caused by the Hepatitis B virus. Its principal function is to support the development of immunity to this serious condition. The administration of the vaccine is considered the most effective way to protect against the virus.

This measure is recommended for a broad range of individuals, including all infants at birth and children who have not previously been vaccinated. Adults through age 59 are generally recommended to receive the vaccine, as are older adults with specified risk factors. Vaccination is also a therapeutic option for older adults without identified risk factors who seek protection.

The use of this preventative treatment is a foundational component of public health strategy aimed at reducing the transmission and prevalence of this viral disease. Achieving the full series of injections is necessary to secure the maximum intended protective benefit against the condition.

Eligibility and Restrictions for Use

Who Can and Cannot Use Shot B (Hepatitis B Vaccine) – Eligibility Summary

This section outlines who is eligible for the recombinant Hepatitis B vaccine (Shot B) and which groups are advised against its use, based on official regulatory labeling.

Eligibility Restrictions

Category Regulatory Status
Contraindication The vaccine must not be used in individuals with a history of severe allergic reaction (e.g., anaphylaxis) to a previous dose of any Hepatitis B vaccine or to any component of the current vaccine product (such as yeast).
Age-Related Specific formulations (e.g., HEPLISAV-B, PreHevbrio) are officially approved only for adults 18 years of age and older. Other formulations are approved for use from birth.
Acute Illness Use should generally be postponed in persons experiencing moderate or severe acute illness, with or without fever.
Bleeding Disorders Individuals with bleeding disorders (e.g., hemophilia) may require administration by the subcutaneous route rather than intramuscular, which may result in a lower immune response.

Eligibility is defined by age for specific brand formulations and is strictly prohibited by a known severe hypersensitivity to the vaccine or its components. Temporary postponement is required for moderate to severe acute illness.

What should I know about interactions with other medicines?

Interactions with other medicines and products

“Shot B,” a common name for two distinct medical injections, has official interaction profiles documented separately by regulatory authorities.

A. Hepatitis B Vaccine Interaction Profile

This profile is primarily defined by pharmacodynamic interference and procedural constraints. Immunosuppressive therapies may result in a diminished immune response, potentially reducing the intended immunological effect. Co-administration of Hepatitis B Immune Globulin (HBIG) is permissible but requires administrative separation; both must be injected at separate sites (e.g., opposite limbs). The vaccine must not be mixed with any other product in the same syringe or vial. The effect of alcohol on the vaccine response is not officially established, and there are no known interactions with food.

B. Cyanocobalamin Injection Interaction Profile

This profile centers on therapeutic antagonism and interference with B12 availability. The antibiotic Chloramphenicol may antagonize the hematopoietic response to cyanocobalamin. Substances that cause malabsorption of the vitamin, such as Colchicine, para-aminosalicylic acid, and heavy alcohol intake for over two weeks, are officially noted as impacting B12 status. Furthermore, agents including most antibiotics, Methotrexate, and Pyrimethamine may invalidate Vitamin B12 diagnostic blood assays. The therapeutic response may also be blunted in patients experiencing concurrent uremia or infection.

Mechanism of Action

How Shot B Works: A Mechanistic Overview

Receptor-Mediated Signaling Modulation

Shot B acts within domains involving specific cell-surface receptors, primarily functioning as a positive allosteric modulator. This mechanism influences key neural pathways by enhancing the inhibitory signal transmission. The resulting physiological effect is an altered membrane potential stability within the targeted neural or cellular circuits.


Regulating Dysregulated Pathways

The drug engages mechanisms that influence overactive physiological processes. This involves modifying early molecular steps in the downstream cascade, which are often driven by distinct, rapid signaling patterns. This targeted pathway adjustment attenuates the duration or magnitude of mediator-dependent signaling, thereby modulating the rate of signal propagation within the biological systems being influenced.


Influence on Feedback Regulation

Shot B is relevant in systems where multiple layers of pathway activation and subsequent feedback regulation occur. It initiates or suppresses signaling sequences that influence this internal feedback loop. By modifying these sequences, the drug results in changes to systemic physiological parameters, which determines the systemic biological consequence of pathway modification.

Dosage and Administration Information

Administration Methods

Shot B is typically administered via intramuscular injection. This process involves the delivery of the solution directly into a large muscle mass, which allows for gradual absorption into the systemic circulation. Common sites for this type of administration include the deltoid muscle of the upper arm, the vastus lateralis muscle of the thigh, or the ventrogluteal muscle of the hip.

Preparation and Handling

Before administration, the solution should be inspected visually for any particulate matter or discoloration. The liquid should be clear; if the solution appears cloudy or contains visible debris, it should not be used. Proper aseptic technique is maintained throughout the preparation process to ensure the sterility of the injection.

Factors Influencing Use

The frequency and duration of use are determined by a healthcare professional based on individual requirements and the specific health objectives being addressed. Absorption rates can vary depending on the injection site chosen and the individual's metabolic rate. It is standard practice to rotate injection sites to maintain skin integrity and muscle health over time.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Shot B (Hepatitis B Vaccine)


Evidence for Primary Prevention of HBV Infection

The research was studied for the primary use of the Hepatitis B vaccine (Shot B) through initial Randomized Controlled Trials (RCTs) to assess immediate immune response, complemented by long-term observational cohort studies that have tracked large populations over decades. Studies primarily monitored the immune system’s response by measuring seroprotection—the level of protective antibodies (anti-HBs) produced after the injections. Research also monitored the long-term patterns related to the incidence of acute infection and the development of chronic Hepatitis B virus (HBV) carriage.

Findings describe patterns observed in these studies, reporting the achievement of seroprotection in a high percentage of healthy recipients shortly after the observed period. Long-term epidemiological studies observed effects on entire populations, describing patterns associated with a long-term lower occurrence of HBV infection and chronic carriage. Research explored the relationship between this lower occurrence of chronic infection and measurements of serious liver conditions, such as liver cancer and cirrhosis.

Long-Term Follow-up and Durability of Immune Markers

Research has explored the longevity of the immune response, with some observational cohort studies following individuals for over 20 to 30 years. These studies monitored the persistence of anti-HBs antibodies, which typically decline over time. Studies explored how immunological memory was associated with low rates of clinical infection over decades, even when specific antibody levels dropped. However, research suggests that the full duration of protection for all vaccinated people is not yet definitively established, requiring research that is ongoing.

Review of Strategies for Waning Immunity (Booster Evidence)

Research has explored instances where protective antibody levels decline over time using challenge-dose studies and systematic reviews to see if an additional injection restores antibody levels. Findings report that a booster injection was associated with a rapid re-achievement of antibody levels in most healthy people who had responded well to the initial series. Comparative evidence is lacking regarding routine boosting for all healthy individuals who retain immunological memory, and certainty remains low in this research area.

Frequently Asked Questions (FAQ)

Common questions about Shot B (FAQ)


Q: Do you feel pain when you get the Shot B injection?

A: Official product information for both the Hepatitis B vaccine and the Vitamin B12 injection lists pain or soreness at the injection site as a common or very common documented reaction. This typically refers to localized, transient discomfort.


Q: How long does it take to start feeling the effects of Shot B?

A: The expected time frame for the effects of Shot B differs depending on the product. For the Vitamin B12 injection, official product information notes that effects such as improvement in blood cell counts and symptoms are often observed within days to a few weeks in study participants. For the Hepatitis B vaccine, the protective antibody response (seroprotection) is described in studies as developing over the course of the multi-dose series.


Q: How long does one dose of Shot B typically last?

A: For the Vitamin B12 injection, the dose is frequently part of a regular, ongoing maintenance plan. For the Hepatitis B vaccine, studies indicate the protective effect of the complete series is long-lasting, with evidence of immunological memory remaining active for over 20 years, even when specific antibody levels decline.


Q: Is it normal to feel a little sick right after getting Shot B?

A: Side effect documentation states that reactions, such as fever, fatigue, and nausea (for the vaccine), or headache and mild diarrhea (for B12), are commonly observed. These documented effects are usually mild and transient.


Q: Can Shot B be used for other issues besides what it's mainly for?

A: Official regulatory documents define the uses of Shot B strictly by indication. The Hepatitis B vaccine is indicated only for active immunization against infection caused by the Hepatitis B virus. The Cyanocobalamin (Vitamin B12) injection is indicated for the treatment and prevention of Vitamin B12 deficiency.


Q: Does Shot B have an effect on sleep or mood?

A: Some documented adverse events of the Vitamin B12 injection (Cyanocobalamin) involve the nervous system, including dizziness and drowsiness. Effects directly related to changes in mood or sleep patterns are not explicitly listed in the core regulatory documents for either product.


Q: Is it true that Shot B can cause weight changes?

A: Weight changes are not listed as a documented adverse reaction in the official regulatory documents for either the Vitamin B12 injection or the Hepatitis B vaccine.


Q: Can I drink alcohol while I am taking Shot B?

A: Official information for the Vitamin B12 injection notes that heavy alcohol intake over a period of more than two weeks may officially impact Vitamin B12 status in the body. For the Hepatitis B vaccine, the effect of alcohol on the body's immune response has not been officially established in regulatory documents.


Q: Does Shot B interact with common pain relievers like ibuprofen?

A: Common over-the-counter pain relievers, such as ibuprofen, are not officially listed among the documented interactions in the regulatory information for either the Vitamin B12 injection or the Hepatitis B vaccine.


Q: Are there any foods or supplements that are known to interact with Shot B?

A: Regulatory documents indicate there are no known interactions between the Hepatitis B vaccine and food. For the Vitamin B12 injection, substances known to cause malabsorption, such as Colchicine, and heavy alcohol use are officially noted as affecting B12 status.


Q: What happens if I miss my scheduled Shot B?

A: For the Hepatitis B vaccine series, official guidance states that a missed dose should be received as soon as possible. There is generally no need to restart the entire vaccine series if a dose is delayed. Official guidance indicates that the scheduled dosing interval is resumed from the date of the missed dose administration.


Q: Does Shot B show up on a drug test?

A: Neither the Hepatitis B vaccine nor the Vitamin B12 injection are typically included in the list of substances monitored by standard drug screens.


Q: How quickly do the side effects of Shot B usually go away?

A: Common side effects for the Hepatitis B vaccine, such as fatigue and injection site reactions, are described as typically mild and generally resolving within a few days. For the Vitamin B12 injection, the mild side effects documented are also usually transient.


Q: Is there a generic version of Shot B available?

A: Yes, the active ingredient in the Vitamin B12 injection, Cyanocobalamin, is widely available as a generic product. For the Hepatitis B vaccine, several recombinant brand formulations are approved by regulatory bodies.


Q: Why are there different doses of Shot B mentioned in studies?

A: Different doses may be described in medical studies due to the evaluation of different brand formulations of the vaccine, the age of the patient group being studied, or the investigation of alternative dosing schedules.


Q: Is it okay to get Shot B if I am taking vitamins?

A: There are no documented contraindications or specific interactions listed related to taking standard oral vitamins concurrently with the Hepatitis B vaccine or the Vitamin B12 injection.


Q: Can Shot B affect my blood pressure?

A: While rare, serious adverse reactions documented for the Vitamin B12 injection include Congestive Heart Failure, which can involve effects on blood pressure. Anaphylactic shock, a rare but serious event for both products, can also affect blood pressure.


Q: Does Shot B make you feel tired or dizzy?

A: Tiredness or fatigue is listed as a very common side effect of the Hepatitis B vaccine. Dizziness and drowsiness are documented side effects associated with the Vitamin B12 injection.


Q: What kind of professional usually gives the Shot B injection?

A: Official administration instructions specify that the injection is usually given by a healthcare professional. In some cases, patients or caregivers may be trained for self-administration.


Q: Is there a risk of becoming dependent on Shot B?

A: Abuse and dependence have not been reported in regulatory documents for either the Hepatitis B vaccine or the Vitamin B12 injection.


Q: Does Shot B affect fertility or reproductive health?

A: Regulatory documents address the use of the products in specific populations, such as pregnancy and lactation. However, effects on fertility or reproductive health are not listed as documented adverse reactions in the official prescribing information.


Q: Does Shot B require special monitoring or lab tests?

A: For the Vitamin B12 injection, healthcare providers may order certain lab tests, such as blood cell counts and Vitamin B12 levels, to check the body's response to the treatment. This is not typically required for the Hepatitis B vaccine.


Q: What should be done if there is a reaction at the injection site?

A: The official protocol to minimize local reactions (like pain, soreness, or swelling) at the injection site is to rotate the site with each administration. Severe reactions are addressed in the Safety section, and any concerns related to injection site issues are generally discussed with a healthcare provider.


Q: How does the body process and eliminate Shot B?

A: For the Vitamin B12 injection, the vitamin is described as being stored primarily in the liver and bound to plasma proteins, with excess amounts being excreted via the urine. The Hepatitis B vaccine works by stimulating the immune system to produce antibodies rather than being metabolized like a drug.


Q: Is it true that Shot B has been around for many years?

A: Yes, both injections have an established history. The Hepatitis B vaccine has been routinely recommended for infants since the 1990s, and the use of injectable Vitamin B12 for deficiency has been established for many decades.


Q: What is the likelihood of experiencing a rare side effect?

A: Serious but rare adverse reactions, such as anaphylaxis, are officially documented. Regulatory bodies typically define a rare event as occurring in between 1 in 1,000 to 1 in 10,000 patients.


Q: Does Shot B have any warnings related to driving or operating machinery?

A: The regulatory label for the Hepatitis B vaccine does not typically include a warning against driving or operating machinery. However, the documented side effects of dizziness and drowsiness associated with the Vitamin B12 injection may potentially affect these abilities.

How should Shot B be stored and disposed of?

How to Store and Dispose of Shot B?

Official regulatory documents define strict storage requirements, which vary based on whether the injection is a vaccine or a vitamin product.

Requirement Hepatitis B Vaccine Cyanocobalamin Injection
Required Temperature Refrigerate (2 C–8 C). Controlled Room Temperature (20 C–25 C).
Mandatory Protection DO NOT FREEZE; protect from light. Avoid freezing; protect from light.
Stability Note Discard if frozen or discolored. Multi-dose vials must be discarded within 28 days of first puncture.
Disposal Rule Unused product must be discarded according to local requirements. Unused medicine can be mixed with undesirable material and thrown in household trash.

All used syringes and needles from either injection must be immediately placed into a dedicated, FDA-cleared sharps disposal container to prevent accidental injury.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Shot B found in:

A-Z Index: